Krishna Institute of Medical Sciences Ltd
Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.
- Market Cap ₹ 31,157 Cr.
- Current Price ₹ 779
- High / Low ₹ 811 / 576
- Stock P/E 126
- Book Value ₹ 56.2
- Dividend Yield 0.00 %
- ROCE 9.29 %
- ROE 11.3 %
- Face Value ₹ 2.00
Pros
- Company is expected to give good quarter
- Company's median sales growth is 21.9% of last 10 years
Cons
- Stock is trading at 13.9 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -4.73%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Select Index BSE 250 SmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 512 | 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 | |
| 403 | 450 | 593 | 833 | 872 | 953 | 1,126 | 1,587 | 1,850 | 2,242 | 3,103 | |
| Operating Profit | 109 | 118 | 71 | 85 | 251 | 377 | 524 | 611 | 648 | 793 | 802 |
| OPM % | 21% | 21% | 11% | 9% | 22% | 28% | 32% | 28% | 26% | 26% | 21% |
| 5 | 3 | 37 | 6 | 5 | 9 | 27 | 41 | 13 | 43 | 18 | |
| Interest | 37 | 32 | 88 | 49 | 44 | 37 | 22 | 37 | 55 | 100 | 202 |
| Depreciation | 36 | 35 | 40 | 56 | 71 | 70 | 73 | 129 | 147 | 177 | 283 |
| Profit before tax | 41 | 53 | -20 | -15 | 141 | 279 | 457 | 485 | 460 | 558 | 334 |
| Tax % | 32% | 37% | 126% | 223% | 18% | 26% | 25% | 25% | 27% | 26% | 28% |
| 28 | 33 | -46 | -49 | 115 | 205 | 344 | 366 | 336 | 415 | 242 | |
| EPS in Rs | 0.76 | 0.91 | -1.32 | -1.28 | 3.20 | 5.19 | 8.32 | 8.41 | 7.75 | 9.61 | 6.03 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 4% |
| 3 Years: | -9% |
| TTM: | -32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 34% |
| 1 Year: | 18% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 70 | 72 | 50 | 74 | 74 | 78 | 80 | 80 | 80 | 80 | 80 |
| Reserves | 193 | 255 | -209 | 466 | 524 | 786 | 1,307 | 1,590 | 1,748 | 2,058 | 2,167 |
| 256 | 280 | 753 | 336 | 369 | 316 | 257 | 678 | 1,355 | 2,557 | 4,253 | |
| 146 | 167 | 359 | 237 | 228 | 253 | 260 | 553 | 636 | 995 | 1,258 | |
| Total Liabilities | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,759 |
| 515 | 518 | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,348 | 5,710 | |
| CWIP | 2 | 64 | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 | 606 |
| Investments | 11 | 14 | 0 | 0 | 0 | 0 | 332 | 68 | 157 | 99 | 103 |
| 137 | 177 | 199 | 250 | 276 | 493 | 546 | 590 | 629 | 1,028 | 1,339 | |
| Total Assets | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,759 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 | 82 | 106 | 134 | 202 | 356 | 324 | 432 | 521 | 582 | 511 | |
| -41 | -100 | -64 | -110 | -125 | -354 | -412 | -416 | -753 | -1,116 | -1,452 | |
| -65 | 24 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 | 940 | |
| Net Cash Flow | -11 | 5 | 3 | -3 | 32 | 12 | -26 | 36 | -15 | 9 | -1 |
| Free Cash Flow | 61 | -18 | 49 | 57 | 150 | 262 | 154 | -140 | -125 | -380 | -902 |
| CFO/OP | 88% | 80% | 192% | 195% | 102% | 104% | 86% | 87% | 102% | 91% | 83% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 59 | 59 | 49 | 43 | 30 | 28 | 42 | 43 | 48 | 52 |
| Inventory Days | 36 | 43 | 46 | 47 | 44 | 30 | 37 | 44 | |||
| Days Payable | 194 | 207 | 215 | 181 | 177 | 167 | 133 | 146 | |||
| Cash Conversion Cycle | -111 | -105 | -110 | -85 | -91 | -106 | -67 | 42 | 43 | 48 | -50 |
| Working Capital Days | 11 | 26 | -333 | -15 | -15 | -31 | -3 | 8 | -5 | -29 | -35 |
| ROCE % | 15% | 11% | 5% | 20% | 29% | 34% | 24% | 17% | 15% | 9% |
Insights
In beta| Mar 2005 | Mar 2010 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Hospitals Number |
|
||||||||||
| ALOS (Average Length of Stay) Days |
|||||||||||
| ARPOB (Average Revenue Per Occupied Bed) INR |
|||||||||||
| Bed Capacity Number |
|||||||||||
| Inpatient (IP) Volume Number |
|||||||||||
| Occupancy Percentage % |
|||||||||||
| Operational Beds Number |
|||||||||||
| Outpatient (OP) Volume Number |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
The Finance & Investment Committee Has, At Its Meeting Held Today,
I.E., 16Th June, 2026, Inter-Alia, Considered And Approved The Following:
(A) Approval And Adoption Of The Preliminary Placement Document Dated 16Th June, 2026 Together With The
Application Form In Connection With The Issue;
(B) Approval And Authorisation Of The Opening Of The Issue Today, I.E., 16Th June, 2026 And
(C) Approved The Floor Price For The Issue As Prescribed Under SEBI ICDR Regulations, Being ? 771.73 Per
Equity Share ('Floor Price'), Based On The Pricing Formula As Prescribed Under Regulation 176 Of The SEBI ICDR
Regulations.
7h - KIMS opens QIP on 16 June 2026; floor price set at ₹771.73 per share, issue price due 19 June.
-
Audited Standalone And Consolidated Financial Statements For The Financial Year Ended 31St March 2026.
15h - Audited standalone and consolidated FY2026 financial statements submitted, subject to shareholder approval at AGM.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E 13.06.2026
13 Jun - Board approved 77.02 lakh warrants at ₹779 each to promoters; EGM scheduled for 9 July 2026.
-
Board Meeting Intimation for Fund Raising
10 Jun - Board meets 13 June 2026 to consider fund raising via securities issuance; trading window closed.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 Jun - KIMS to attend Equirus Annual India Conference in Mumbai on August 14, 2026.
Annual reports
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptAI SummaryPPT
-
May 2022Transcript PPT
-
May 2022TranscriptAI SummaryPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Oct 2021TranscriptAI SummaryPPT
-
Aug 2021Transcript PPT
Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]